0001209191-24-002739.txt : 20240205
0001209191-24-002739.hdr.sgml : 20240205
20240205060014
ACCESSION NUMBER: 0001209191-24-002739
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240204
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONSIGLIO RONALD J
CENTRAL INDEX KEY: 0001232088
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50865
FILM NUMBER: 24593787
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MANNKIND CORP
CENTRAL INDEX KEY: 0000899460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133607736
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 818-661-5000
MAIL ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-04
0
0000899460
MANNKIND CORP
MNKD
0001232088
CONSIGLIO RONALD J
1 CASPER STREET
DANBURY
CT
06810
1
0
0
0
0
Common Stock, $0.01 Par Value
2024-02-04
4
A
0
25000
3.27
A
545997
D
The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on February 4, 2024.
/s/ Ron Consiglio
2024-02-05